
Korea turns to Nordics, Novo Nordisk to cross biotech ‘valley of death’
Korea is tired of watching biohealth breakthroughs stall in the lab. With four out of five high-risk R&D projects failing to cross the finish line, the country is looking outward -- toward Nordic biotech hubs and global pharma giants -- to bridge what …